Winning Together, Grateful for You | Huizhong Bio’s Year-End Appreciation Event (Liaoning Station) Concluded Successfully

On December 14, Huizhong Bio’s year-end appreciation event (Liaoning Station) was grandly held in Shenyang. A total of 70 participants, including partners and expert scholars from across Liaoning Province, attended the event. The meeting was chaired by Shi Shan Hui, General Manager of Tianhe Furuida in Liaoning, and was attended by company leaders such as Yao Changgang, Deputy General Manager of Huizhong Bio’s Swine Vaccine Division. At the opening, Yao Changgang, Deputy General Manager of Huizhong Bio’s Swine Vaccine Division, delivered a speech, expressing gratitude for the long-term support of their partners. He stated: “Against the backdrop of African swine fever becoming endemic, Huizhong Bio’s Round‑Support 3.0 combination—designed to enhance efficacy while reducing costs—has earned high recognition from both the market and users. It has made significant contributions to minimizing stress and infection, lowering pig‑raising expenses, and advancing combined vaccine immunization within the industry. Furthermore, our company offers highly effective products for the currently prevalent porcine epidemic diarrhea, and we have introduced small‑dose packaging to better meet the needs of family‑run pig farms in northern China. At present, Huizhong Bio holds an absolute advantage in developing, applying, and combining high‑end multivalent vaccines for joint immunization.” Yao’s remarks instilled strong confidence in the company and its products among the attending distributors. ▲ Yao Changgang, Deputy General Manager of Huizhong Bio’s Swine Vaccine Division, delivers a speech. Professor Li Lishan from Jinzhou Medical University presented a detailed report on “Current Measures for Controlling Porcine Epidemics.” Professor Li pointed out: “Mycoplasma hyopneumoniae infection is a major factor complicating the prevention and control of respiratory diseases and PRRS in pigs today. With a high infection rate, this pathogen can easily cause pigs to breathe at 20–30 breaths per minute, leading to pulmonary consolidation. The most effective way to prevent and control this disease is vaccination; combining it with circovirus immunization yields even better results. Meanwhile, strains of porcine epidemic diarrhea have been mutating for years, making it essential to select prevailing strains and adopt a live‑plus‑inactivated combined immunization approach as the most cost‑effective and efficient preventive strategy.” ▲ Professor Li Lishan from Jinzhou Medical University shares technical insights. Professor Liu Xianjun from Shenyang Agricultural University provided an in-depth analysis of “Biosafety and Disease Prevention under the Context of African Swine Fever.” He thoroughly discussed the structural adjustments, technological upgrades, cost management challenges, and restrictions on live pig transportation facing China’s pig‑raising industry amid ASF. Using historical data on sow culling and inventory levels, along with import/export pork trade figures, he highlighted that future sow inventories are expected to decline further, resulting in a two-tiered landscape where large-scale operations coexist with smallholder farms—both requiring enhanced farming techniques. Professor Liu also emphasized that banning antibiotics is an inevitable trend, and that disease prevention should prioritize biosafety measures combined with highly effective vaccines, with combined vaccines and water‑adjuvanted formulations representing the emerging trend. ▲ Professor Liu Xianjun from Shenyang Agricultural University shares technical insights. During the conference, company leaders honored and encouraged outstanding partners, expressing gratitude for their trust and support. They expressed hope that, moving forward, all parties will continue to collaborate sincerely, advance together, and jointly prosper alongside the livestock industry. ▲ Winners of the Outstanding Distributor Award.

On December 14, Huizhong Bio’s year-end appreciation event (Liaoning stop) was held with great fanfare in Shenyang. A total of 70 participants, including partners and academic experts from across Liaoning Province, attended the gathering. The meeting was chaired by Shi Shan Hui, General Manager of Tianhe Furuida in Liaoning, and was graced by the presence of company leaders, including Yao Changgang, Deputy General Manager of Huizhong Bio’s Swine Vaccine Division.

At the opening of the meeting, Yao Changgang, Deputy General Manager of Huizhong Bio’s Pig Vaccine Division, delivered a welcoming address. Mr. Yao expressed his gratitude to partners for their longstanding support, noting: “Against the backdrop of ASF becoming endemic, Huizhong Bio’s Yuanzhi 3.0—our enhanced‑efficacy, cost‑reducing formulation—has earned widespread recognition from both the market and end users. It has made significant contributions to minimizing stress and infection, lowering pig‑raising costs, and advancing combined‑vaccine immunization across the industry. In addition, our company offers highly effective products for the currently prevalent porcine epidemic diarrhea, and we have introduced small‑dose packaging to better meet the needs of family‑run farms in northern China. Today, Huizhong Bio enjoys a clear competitive edge in the development, combined application, and integrated immunization of high‑end multivalent vaccines.” Mr. Yao’s remarks left the attending distributors thoroughly confident in the company and its products.

▲ Yao Changgang, Deputy General Manager of the Piglet Division at Huizhong Bio, delivered a speech.

Professor Li Lishan of Jinzhou Medical University delivered a detailed report on “Current Measures for the Prevention and Control of Swine Epidemics.” Professor Li pointed out: “Mycoplasma hyopneumoniae infection is a major factor contributing to the increasing complexity and difficulty in managing swine respiratory diseases and PRRS. This pathogen has a high prevalence and can readily elevate respiratory rates to 20–30 breaths per minute, leading to pulmonary consolidation. The most effective approach to controlling this disease is vaccination; combining it with circovirus immunization yields even better results. Moreover, strains of porcine epidemic diarrhea have been undergoing mutation for many years, so selecting the prevailing strain and employing a live‑plus‑inactivated vaccine combination represents the most cost‑effective and efficient control strategy.”

▲ Professor Li Lishan of Jinzhou Medical University delivers a technical presentation.

Professor Xianjun Liu of Shenyang Agricultural University delivered an in-depth analysis on “Biosecurity and Disease Prevention and Control in the Context of African Swine Fever.” Professor Liu thoroughly outlined the challenges confronting China’s pig industry under this pandemic, including structural adjustments, the need to upgrade technological capabilities, the management of production costs, and restrictions on the movement of live pigs. Drawing on historical data on sow inventory and marketings, as well as import‑export pork trade figures, he demonstrated that sow inventories are likely to continue declining, leading to a two-tiered landscape in which large-scale operations coexist with smallholder farms—both groups will need to enhance their swine‑raising technologies. Professor Liu also argued that phasing out antibiotic use is an inevitable path forward, emphasizing that disease prevention and control should prioritize biosecurity combined with highly effective vaccines, with combination vaccines and water‑adjuvanted formulations representing the prevailing trend.

▲ Professor Liu Xianjun of Shenyang Agricultural University delivers a technical presentation.

During the conference, company leaders presented awards and offered words of encouragement to outstanding partners, expressing their gratitude for their trust and support. They also expressed the hope that, in the days ahead, they will continue to collaborate sincerely, advance hand in hand, and achieve shared prosperity in the livestock industry.

▲ Winner of the Outstanding Dealer Award

Recommended News

ABOUT US

Huizhong Biotech

Upright and Stable Operation Innovation Creates the Future